Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Phytochemistry

Ibuprofen-like activity in extra-virgin olive oil

Enzymes in an inflammation pathway are inhibited by oleocanthal, a component of olive oil.

Abstract

Newly pressed extra-virgin olive oil contains oleocanthal — a compound whose pungency induces a strong stinging sensation in the throat, not unlike that caused by solutions of the non-steroidal anti-inflammatory drug ibuprofen1. We show here that this similar perception seems to be an indicator of a shared pharmacological activity, with oleocanthal acting as a natural anti-inflammatory compound that has a potency and profile strikingly similar to that of ibuprofen. Although structurally dissimilar, both these molecules inhibit the same cyclooxygenase enzymes in the prostaglandin-biosynthesis pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Structures of (−)oleocanthal (left) and the anti-inflammatory drug ibuprofen (right).

Similar content being viewed by others

References

  1. Breslin, P. A. S., Gingerich, T. N. & Green, B. G. Chem. Sens. 26, 55–66 (2001).

    Article  CAS  Google Scholar 

  2. Andrewes, P., Busch, J. L. H. C., De Joode, T., Groenewegen, A. & Alexandre, H. J. Agric. Food Chem. 51, 1415–1420 (2003).

    Article  CAS  PubMed  Google Scholar 

  3. Fischer, R., Griffen, F., Archer, R. C., Zinsmeister, S. C. & Jastram, P. S. Nature 207, 1049–1053 (1965).

    Article  ADS  CAS  PubMed  Google Scholar 

  4. Vane, J. R. & Botting, R. M. Inflamm. Res. 44, 1–10 (1995).

    Article  CAS  PubMed  Google Scholar 

  5. Harris, R. E., Beebe-Donk, J., Doss, H. & Burr Doss, D. Oncol. Rep. 13, 559–583 (2005).

    CAS  PubMed  Google Scholar 

  6. Zhou, Y. et al. Science 302, 1215–1217 (2003).

    Article  ADS  CAS  PubMed  Google Scholar 

  7. Hu, F. N. Engl. J. Med. 348, 2595–2596 (2003).

    Article  PubMed  Google Scholar 

  8. Tuck, K., Freeman, M., Hayball, P., Stretch, G. & Stupans, I. J. Nutr. 131, 1993–1996 (2001).

    Article  CAS  PubMed  Google Scholar 

  9. Miro-Casas, E. et al. Clin. Chem. 49, 945–952 (2003).

    Article  CAS  PubMed  Google Scholar 

  10. Hennekens, C. H. Am. J. Man. Care 8 (suppl.), 691–700 (2002).

    Google Scholar 

  11. Lefer, A. M., Muller, H. F. & Smith, J. B. Br. J. Pharmacol. 83, 125–130 (1984).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Togna, G. I., Togna, A. R., Franconi, M., Marra, C. & Guiso, M. J. Nutr. 133, 2532–2536 (2003).

    Article  CAS  PubMed  Google Scholar 

  13. Mitchell, J. A. et al. Proc. Natl Acad. Sci. USA 90, 11693–11697 (1993).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul A. S. Breslin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beauchamp, G., Keast, R., Morel, D. et al. Ibuprofen-like activity in extra-virgin olive oil. Nature 437, 45–46 (2005). https://doi.org/10.1038/437045a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/437045a

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing